| 168061 | 168061 | NExT ERA: National Expertise Based Trial of Elective Repair of Abdominal Aortic Aneurysms: A Pilot Study | Not yet recruiting | No Results Available | Aortic Aneurysm, Abdominal | Procedure: Endovascular Repair of Abdominal Aortic Aneurysm|Procedure: Conventional open repair of Abdominal Aortic Aneurysm | https://ClinicalTrials.gov/show/NCT00358085 |
| 168062 | 168062 | Treatment of Adult ALL With an MRD-directed Programme. | Completed | No Results Available | Acute Lymphoblastic Leukemia | Behavioral: Postremission consolidation based on MRD status | https://ClinicalTrials.gov/show/NCT00358072 |
| 168063 | 168063 | Behavior Therapy for Families of Diabetic Adolescents | Completed | No Results Available | Type 1 Diabetes Mellitus | Behavioral: Behavioral Family Systems Therapy for Diabetes | https://ClinicalTrials.gov/show/NCT00358059 |
| 168064 | 168064 | Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia | Active, not recruiting | No Results Available | Kidney Diseases|Renal Insufficiency | Drug: ILY101 | https://ClinicalTrials.gov/show/NCT00358046 |
| 168065 | 168065 | Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic | Completed | No Results Available | Diabetes|Dyslipidemia|Hypertension|Coronary Atherosclerosis | Behavioral: Counseling|Behavioral: Interactive Education|Behavioral: Group Support|Procedure: Pharmacologic case management | https://ClinicalTrials.gov/show/NCT00358033 |
| 168066 | 168066 | Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients | Completed | No Results Available | Multiple Myeloma | Drug: THALIDOMIDE|Drug: BORTEZOMIB | https://ClinicalTrials.gov/show/NCT00358020 |
| 168067 | 168067 | Use of Cone Beam Kilovoltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer | Terminated | Has Results | Head and Neck Neoplasms | Device: PTV Reduction | https://ClinicalTrials.gov/show/NCT00358007 |
| 168068 | 168068 | Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects | Completed | Has Results | Advanced Parkinson's Disease | Drug: Levodopa carbidopa intestinal gel (LCIG)|Drug: Placebo gel|Drug: Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets|Drug: Placebo (PBO) oral capsules|Device: CADD-Legacy® 1400 ambulatory infusion pump|Device: PEG tube|Device: J-tube | https://ClinicalTrials.gov/show/NCT00357994 |
| 168069 | 168069 | Continuous Use of the Contraceptive Patch and the Personal Economic Impact. | Withdrawn | No Results Available | Dysmenorrhea|Menstruation Disturbances|Menstruation Disorders | Drug: ORTHO EVRA, the contraceptive patch | https://ClinicalTrials.gov/show/NCT00357981 |
| 168070 | 168070 | Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting | Completed | Has Results | Coronary Artery Disease | Drug: Prasugrel|Drug: Clopidogrel|Drug: Placebo for Prasugrel|Drug: Placebo for Clopidogrel | https://ClinicalTrials.gov/show/NCT00357968 |
| 168071 | 168071 | Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients | Completed | Has Results | Diabetes|Hypertension|Dyslipidemia|Coronary Arteriosclerosis | Behavioral: Behavioral counseling and peer support|Behavioral: Interactive Education|Behavioral: Role modeling|Procedure: Pharmacologic case management | https://ClinicalTrials.gov/show/NCT00357955 |
| 168072 | 168072 | Topical Morphine for Stomatitis-related Pain Induced by Chemotherapy | Completed | No Results Available | Pain|Mucositis | Drug: morphine solution for injection|Drug: Placebo|Drug: morphine mouthwash|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00357942 |
| 168073 | 168073 | Weaning From Mechanical Ventilation Using Permissive Hypercarbia | Terminated | No Results Available | Respiration, Artificial|Respiratory Distress Syndrome, Adult | Procedure: Permissive hypercarbia | https://ClinicalTrials.gov/show/NCT00357929 |
| 168074 | 168074 | Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design | Completed | No Results Available | Healthy | Drug: PEP005 Topical Gel (0.01% concentration) | https://ClinicalTrials.gov/show/NCT00357916 |
| 168075 | 168075 | Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials | Completed | Has Results | Rheumatoid Arthritis | Biological: Etanercept | https://ClinicalTrials.gov/show/NCT00357903 |
| 168076 | 168076 | Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D) | Completed | No Results Available | Diabetes Mellitus, Insulin-Dependent | Device: Pump therapy (CSII)|Drug: Multiple daily injections (MDI) using insulin glargine + rapid acting analog | https://ClinicalTrials.gov/show/NCT00357890 |
| 168077 | 168077 | Prevention of Adult Caries Study (PACS) | Active, not recruiting | No Results Available | Caries. | Drug: 10% w/v chlorhexidine acetate coating FDA IND #45466 | https://ClinicalTrials.gov/show/NCT00357877 |
| 168078 | 168078 | Carbachol´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow | Completed | No Results Available | Headache | Drug: carbachol | https://ClinicalTrials.gov/show/NCT00357864 |
| 168079 | 168079 | Can Aprotinin Reduce Pancreatitis After Scoliosis Surgery | Completed | No Results Available | Pancreatitis | Drug: Aprotinin | https://ClinicalTrials.gov/show/NCT00357851 |
| 168080 | 168080 | Pulse Waves and Tongue Diagnosis Differences Between Follicular and Luteal Phase in Normal Healthy Women | Recruiting | No Results Available | Healthy | | https://ClinicalTrials.gov/show/NCT00357838 |
| 168081 | 168081 | A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia | Completed | No Results Available | Pain | Drug: [S,S]-Reboxetine | https://ClinicalTrials.gov/show/NCT00357825 |
| 168082 | 168082 | The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK) | Completed | No Results Available | Herpes Simplex Keratitis | | https://ClinicalTrials.gov/show/NCT00357812 |
| 168083 | 168083 | VeinViewer for Peripheral IV Placement in Children With Difficult Intravenous (IV) Access | Completed | No Results Available | Catheterization, Peripheral|Phlebotomy | Device: VeinViewer | https://ClinicalTrials.gov/show/NCT00357799 |
| 168084 | 168084 | An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal in Patients With Fabry Disease | Completed | No Results Available | Fabry Disease | Drug: Replagal agalsidase alfa|Drug: Replagal | https://ClinicalTrials.gov/show/NCT00357786 |
| 168085 | 168085 | Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis | Completed | No Results Available | Conjunctivitis, Bacterial | Drug: Azithromycin (T1225) | https://ClinicalTrials.gov/show/NCT00357773 |
| 168086 | 168086 | Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer | Active, not recruiting | No Results Available | Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer | Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Biological: Ziv-Aflibercept | https://ClinicalTrials.gov/show/NCT00357760 |
| 168087 | 168087 | AEG35156 and Docetaxel in Treating Patients With Solid Tumors | Completed | No Results Available | Unspecified Adult Solid Tumor, Protocol Specific | Drug: AEG35156|Drug: docetaxel | https://ClinicalTrials.gov/show/NCT00357747 |
| 168088 | 168088 | Iressa Follow-up Trial | Completed | No Results Available | Lung Cancer|Breast Cancer | Drug: Gefitinib | https://ClinicalTrials.gov/show/NCT00357734 |
| 168089 | 168089 | Atazanavir Twice Daily | Completed | No Results Available | HIV Infections|Protease Inhibitor | Drug: Atazanavir Sulphate|Drug: Atazanavir Sulphate|Drug: Atazanavir Sulphate | https://ClinicalTrials.gov/show/NCT00357721 |
| 168090 | 168090 | Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases | Completed | No Results Available | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22 | Drug: decitabine|Drug: vorinostat|Other: laboratory biomarker analysis|Other: pharmacological study | https://ClinicalTrials.gov/show/NCT00357708 |